- cafead   Feb 09, 2023 at 06:22: PM
via The Food and Drug Administration will permit Intarcia Therapeutics to request a public advisory committee hearing for its diabetes drug-eluting implant following two previous rejections over its kidney and heart risks.
article source
article source